Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

January 11, 2023

Study Completion Date

January 11, 2023

Conditions
Fibrous DysplasiaAlbright SyndromeAdult ChildrenHypoparathyroidismHyperparathyroidismPseudo Hypoparathyroidism
Interventions
BIOLOGICAL

blood sample

blood sample for circulating autotaxin measurement (5ml).

Trial Locations (3)

69003

Centre de référence Dysplasie Fibreuse des os Service rhumatologie et pathologie osseuse Hôpital Edouard Herriot, Lyon, Lyon

69500

Centre de compétence des maladies rares de l'insulino-sécrétion et de l'insulino-sensibilité, Bron

94270

Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate Service d'Endocrinologie et Diabète de l'Enfant Hôpital Bicêtre Paris Saclay, Paris

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04671719 - Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities | Biotech Hunter | Biotech Hunter